Q3 2026 Mold-Tek Packaging Ltd Earnings Call Transcript
Key Points
- Mold-tek Packaging Ltd (BOM:533080) reported a 20% increase in EBITDA over the nine months compared to the previous year.
- Sales are up by 12% in value terms, with a 6% increase in sales volumes for Q3 year-over-year.
- The company has consolidated its manufacturing units in Hyderabad, reducing from five to two units, which is expected to improve operational efficiencies and cost controls.
- Mold-tek has signed an MOU with Vibe Generation for developing product patents in India, with pilot molds expected to be ready soon.
- The pharma segment shows promise with over 25 clients having cleared production premises, indicating potential for significant volume growth in upcoming quarters.
- Q3 is traditionally the weakest quarter for Mold-tek Packaging Ltd (BOM:533080), and this year was no exception.
- The company faced a decline in lubricant volumes, with a 10% drop attributed to not participating in low-grade lubricant markets and losing a BPCL tender.
- The overall volume growth for the year is expected to be lower than initially projected due to extended rainfall affecting operations.
- There is competitive pressure in the IML segment, although Mold-tek has managed to retain most clients.
- The company's CapEx is expected to decrease significantly next year, which may impact future growth opportunities if not managed carefully.
Ladies and gentlemen, good day, and welcome to the Mold-Tek Packaging Limited Q3 FY26 earnings conference call, hosted by Emkay Global Financial Services Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Mohit Dodeja. Thank you, and over to you, sir.
Yes. Hi. Good evening, everyone. I would like to welcome Mr. Lakshmana Rao, Chairman and Managing Director, and thank him for this opportunity. I shall now hand over the call to him for the opening remarks. Over to you, sir.
Good afternoon, everybody. Thank you very much for joining in our Q3 results call. You might have already seen the results published on BSE and NSE that we have the EBITDA by almost 20% in the nine months compared to the previous nine months, and sales are up by around 12% in value terms.
And
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
